Protection from apoptosis and chemoresistance mediated by microenvironment and CXCR4/CXCL12 axis is well known in ALL or CLL, but not known yet in other NHL subtypes. This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.